Catalyst Event
Johnson & Johnson (JNJ) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
3/18/2026, 12:00:00 AM
The U.S. Food and Drug Administration (FDA) is expected to approve Icotyde (icotrokinra) on March 18, 2026, for treating moderate-to-severe plaque psoriasis; analysts forecast the drug to achieve blockbuster sales. High impact estimated due to significant revenue potential forecasted.
Korean Translation
2026년 3월 18일 미국 FDA의 아이코타이드(Icotyde) 승인이 예상됨. 분석가들은 이 약물이 블록버스터급 매출을 달성할 것으로 전망됨.
Related Recent Events
Meta Platforms Inc (META) · Other
Meta will officially shut down VR access to its social platform Horizon Worlds on June 15, 2026, as part of a strategic shift away from its initial metaverse vision. Low importance as this strategic shift is estimated to have >=1% price impact scheduled.
6/15/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies is scheduled to release its fiscal year 2027 first-quarter financial results on May 28, 2026; High importance as quarterly earnings for major AI infrastructure providers typically result in ≥10% price impact, scheduled.
5/28/2026, 12:00:00 AM
Costco Wholesale Corp (COST) · Earnings Release
Q3 2026 earnings release on May 28, 2026. Medium importance estimated based on historical price volatility during earnings, expected.
5/28/2026, 12:00:00 AM
Dynatrace Inc (DT) · Earnings Release
Q4 and full fiscal year 2026 earnings release is scheduled for May 20, 2026. The date is an estimate based on past reporting schedules, and a Low impact is estimated as the market typically anticipates these regular reporting dates, scheduled.
5/20/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK's 2026 annual meeting of shareholders is scheduled to be held virtually on May 20, 2026, with a record date of March 23, 2026. Market impact is estimated at 1% as the meeting typically addresses routine corporate governance matters, scheduled.
5/20/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Q1 2026 earnings release, which is estimated to have a medium impact due to typical price volatility surrounding financial reports, is scheduled.
5/14/2026, 12:00:00 AM